Get the Stockscreener App
464.56
0.54%
-2.51
After Hours:
464.56
Vertex Pharmaceuticals Inc Stock (VRTX) Latest News
MetLife Investment Management LLC Sells 1,828 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Vertex Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
VRTX (Vertex Pharmaceuticals) Inventory-to-Revenue : 0.36 (As of Sep. 2024) - GuruFocus.com
Fmr LLC Decreases Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Dai ichi Life Insurance Company Ltd Lowers Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Bought by Bank of Montreal Can - MarketBeat
The Manufacturers Life Insurance Company Sells 11,350 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
JPMorgan's 2025 Biotech Outlook: Vertex (VRTX) Leads the Pack - GuruFocus.com
Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
Vertex leads J.P. Morgan's top biotech picks list for 2025 (NASDAQ:VRTX) - Seeking Alpha
Vertex Pharma: Why I Am Buying This Dip (NASDAQ:VRTX) - Seeking Alpha
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Purchased by Eagle Asset Management Inc. - MarketBeat
Loomis Sayles & Co. L P Has $1.43 Billion Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Vertex Pharmaceuticals (NASDAQ:VRTX) shareholders are still up 137% over 3 years despite pulling back 3.4% in the past week - Yahoo Finance
Daiwa Securities Group Inc. Increases Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Down 47% Since March, Is CRISPR Therapeutics Stock a Buy on the Dip? - The Motley Fool
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by Connor Clark & Lunn Investment Management Ltd. - MarketBeat
Pacer Advisors Inc. Sells 5,885 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
VRTX (Vertex Pharmaceuticals) Cash Flow from Investing : $-3,835 Mil (TTM As of Sep. 2024) - GuruFocus.com
Vertex Pharmaceuticals Inc. stock rises Friday, still underperforms market - MarketWatch
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Bought by Icon Wealth Advisors LLC - MarketBeat
Edgewood Management LLC Has $719.19 Million Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
What is Zacks Research's Estimate for VRTX FY2024 Earnings? - MarketBeat
Charles Schwab Investment Management Inc. Increases Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Intech Investment Management LLC Has $8.24 Million Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Goldman Sachs: Vertex Pharmaceuticals Incorporated (VRTX) Is A Top Growth Investor Stock - Insider Monkey
Got $500? 1 Biotech Stock to Buy and Hold Forever - Yahoo! Voices
MAI Capital Management Reduces Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Vertex Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors - MarketWatch
BofA flags Vertex Pharma stock at risk of double top breakdown - Investing.com
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by BNP PARIBAS ASSET MANAGEMENT Holding S.A. - MarketBeat
January 2025 Options Now Available For Vertex Pharmaceuticals (VRTX) - Nasdaq
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by Citizens Financial Group Inc. RI - MarketBeat
Massachusetts Financial Services Co. MA Raises Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Integrated Investment Consultants LLC Invests $9.18 Million in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
PNC Financial Services Group Inc. Increases Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Vertex Pharmaceuticals (NASDAQ:VRTX) Downgraded to "Buy" Rating by StockNews.com - MarketBeat
Advisors Asset Management Inc. Boosts Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Bought by Portfolio Design Labs LLC - MarketBeat
EULAV Asset Management Cuts Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Purchased by Jennison Associates LLC - MarketBeat
MWA Asset Management Sells 2,018 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
57,825 Shares in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Purchased by Segall Bryant & Hamill LLC - MarketBeat
Northwest Bancshares Inc. Sells 2,683 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know - MSN
Strategy Asset Managers LLC Has $1.26 Million Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Acquired by Prospera Financial Services Inc - MarketBeat
Pathstone Holdings LLC Purchases 2,112 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Bought by Quest Partners LLC - MarketBeat
Vertex Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
B. Metzler seel. Sohn & Co. Holding AG Purchases New Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Banque Cantonale Vaudoise Buys 8,720 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by W.G. Shaheen & Associates DBA Whitney & Co - MarketBeat
Whalen Wealth Management Inc. Makes New Investment in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
First Turn Management LLC Trims Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Stock Position Reduced by Thrivent Financial for Lutherans - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Purchased by OneDigital Investment Advisors LLC - MarketBeat
Vertex Pharmaceuticals Inc. stock rises Monday, still underperforms market - MarketWatch
10 Biggest Biotechnology Companies - Investopedia
Braun Stacey Associates Inc. Sells 5,361 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Acquired by Swiss National Bank - MarketBeat
Atlanta Consulting Group Advisors LLC Purchases 1,331 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Empowered Funds LLC Sells 17,482 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Natixis Advisors LLC Grows Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Stock Position Lifted by Mizuho Securities USA LLC - MarketBeat
Kentucky Retirement Systems Trims Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
CIBC Asset Management Inc Has $37.25 Million Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by Impax Asset Management Group plc - MarketBeat
Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch
Broderick Brian C Increases Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by Huntington National Bank - MarketBeat
Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Rating Upgraded by Citigroup - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Stake Increased by KBC Group NV - MarketBeat
0.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):